Lead the development and direction of the Ipsen International (EX US & Canada) evidence generation strategy (Phase IV, ISS, RWE) to support Ipsen’s medical objectives across all therapeutic areas (Oncology, Rare diseases and Neurotoxins).
Responsibilities
Developing strategies for evidence generation (Phase IV, ISS, RWE) at International that support healthcare clinical evidence gaps and the LCM of our products
Assess the local needs and build proposal for scaling RWE capabilities (HC, resources, operating model) at International countries
Define and implement the International Evidence Generation Plan (IEGP) in alignment with global medical strategies and local evidence needs
Provide budget input for activities related to Epidemiology and RWE studies and initiatives ensuring projects are adequately resourced
Ensure that the Global IEGP is well implemented at local level and the country data gaps are well integrated in the IEGP (Global & Local) in alignment with lifecycle management (LCM) priorities
Requirements
Advanced degree in life sciences, medicine, epidemiology, or related field (MD, PharmD, PhD preferred)
The Principal Scientist/Director, Value & Implementation (V&I) Outcomes Research, position supports value evidence outcomes research plans and real-world evidence activities for pipeline products to meet the value evidence needs of clinicians, payers, policymakers, health technology assessment (HTA)/reimbursement agencies and health systems globally.
Locations (3)
Rahway, New Jersey, United States
San Francisco, California, United States
Los Angeles, California, United States
Compensation
The salary range for the primary location of this role is: $190,800.00 - $300,300.00
Responsibilities
Partners with Medical Affairs counterparts to develop, execute and deliver on the Value and Implementation (V&I) plan.
Helps achieve / sustain reimbursement and market access for the oncology program and indications under their responsibility.
Principal Scientist (Director) - Outcomes Research, Oncology Assets
Lead value evidence and outcomes research for oncology products, supporting reimbursement and market access strategies globally.
Compensation
$190,800.00 - $300,300.00
Responsibilities
Partner with Medical Affairs to develop and execute Value and Implementation plans
Achieve and sustain reimbursement and market access for oncology programs
Assess drivers and barriers to reimbursement and market access
Design studies, author protocols, develop questionnaires, case report forms, data analysis plans, reports, presentations, and publications
Manage study contracting, budgets, and vendor/partner relationships
Requirements
Master’s degree in health services research, outcomes research, epidemiology, public health, health economics, pharmacoeconomics, or pharmacy administration
Shape the scientific narrative in amyloidosis and turn robust evidence into actions that change patient outcomes.
Compensation
69.475,20 - 104.212,80 EUR Annual
Responsibilities
KOL strategy and engagement: Identify, map, and develop Key Opinion Leaders; build trusted scientific relationships that surface insights, inform plans, and enhance external credibility.
Medical plan and project leadership: Own delivery of the medical plan and lead local clinical, observational, and diagnostic screening projects with cross-functional partners—on time, on budget, and with measurable impact.
Scientific excellence: Build and continuously deepen expertise in amyloidosis and our therapies; monitor literature and data, then translate learnings into clear guidance, actions, and field enablement.
Compliance and governance: Uphold local laws, codes, and internal policies across all materials, activities, and educational programs to ensure ethical, compliant operations.
Medical education and materials: Create high-quality educational content and provide scientific support for the development, review, and approval of materials for scientific meetings, symposia, and other medical education activities.
Requirements
Advanced scientific or medical degree (e.g., MD, PharmD, PhD) with focus in amyloidosis or related disciplines.
Critically assesses drivers and barriers to reimbursement and market access, and provides input into clinical, regulatory, payer/access, marketing and evidence generation strategies and programs.
In collaboration with internal teams and external partners, designs studies; authors study protocols; and develops measurement questionnaires, case report forms, data analysis plans, final study reports, scientific presentations, and publications.
Responsible for study-related contracting, budgets, and vendor/partner management and ensures study conduct is aligned with company Policies and standard operating procedures (SOPs) and world-wide regulations and standards, including Good Pharmacoepidemiology Practice (GPP) for applicable work.
Requirements
Master’s degree in relevant discipline (health services research, outcomes research, epidemiology, public health, health economics, pharmacoeconomics, pharmacy administration)